SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Targacept (TRGT)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (27)7/31/2007 8:39:38 AM
From: dr.praveenRead Replies (1) of 40
 
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation

W J de Jonge1,2 and L Ulloa3,4

1. 1Department of Gastroenterology, Academic Medical Center, Amsterdam, The Netherlands
2. 2Sir William Dunn School of Pathology, University of Oxford, Oxford, UK
3. 3The Feinstein Institute for Medical Research, North Shore University Hospital, Manhasset, NY, USA
4. 4Laboratory of Surgical Science Research, MSB-F673, UMDNJ-University of Medicine of New Jersey, Newark, NJ, USA

Correspondence: Dr WJ de Jonge, Department of Gastroenterology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam. The Netherlands. E-mails: w.j.dejonge@amc.nl or Mail@LuisUlloa.com

Received 21 December 2006; Revised 28 February 2007; Accepted 27 March 2007; Published online 14 May 2007.

nature.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext